Synthesis and structure-activity relationships of novel compounds for the inhibition of TNF-alpha production

Arch Pharm Res. 2000 Aug;23(4):332-7. doi: 10.1007/BF02975443.

Abstract

This study describes the synthesis, in vitro evaluation and molecular modeling study of novel compounds for the inhibition of TNF-alpha production. Among these compounds, 2-[3-(cyclopentyloxy)-4-methoxyphenyl]-1-isoindolinone (9) was selected as a lead compound and its pyridine derivative 10 was more potent in activity and safer than rolipram.

MeSH terms

  • Animals
  • Mice
  • Models, Biological
  • Phosphodiesterase Inhibitors / pharmacology
  • Rolipram / pharmacology
  • Structure-Activity Relationship
  • Thalidomide / pharmacology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Phosphodiesterase Inhibitors
  • Tumor Necrosis Factor-alpha
  • Thalidomide
  • Rolipram